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CLINICAL INVESTIGATION
Azotemia and extrarenal manifestations in old female Han:SPRD
(cy/+) rats
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Medical Research Center and V. Medical Department, Klinikum Mannheim, University of Heidelberg, Mannheim, Germany
Azotemia and extrarenal manifestations in old female Han:SPRD
(cyl+) rats. In humans suffering from polycystic kidney disease (PKD) a
gender difference is seen with males exhibiting a faster rate of progression
of chronic renal failure than females. The aim of this study was to examine
renal function in female rats suffering from autosomal dominant PKD
[Han:SPRD (cyI+) and to look for the occurrence of extrarenal organ
manifestations of PKD. In young (2 months) as well as in old female rats
(21 months) relative kidney weight was greater in affected than unaffected
animals. In contrast, only the old affected female rats developed azotemia
(serum urea 95 124 mgldl) and severe cystic kidney transformation.
Furthermore, old affected female rats exhibited liver cysts (affected 42%;
unaffected3%) and pancreatic cysts (affected 69%; unaffected 15%). Liver
cyst epithelia stained positive for cytokeratin 19, a marker for bile duct
epithelia. By immunohistochemistry liver cysts exhibited a similar extra-
cellular matrix composition as observed in renal cysts of the same animals
(staining positive for laminin, fibronectin and heparan sulfate proteogly-
can, but not collagen I). This study proves PKD in the Han:SPRD (cy/+)
rat model to be a truly multiorgan disease with a close resemblance of the
human disease.
The autosomal dominant form of polycystic kidney disease
(PKD) with its prevalence of 1:1000 is the most common hered-
itary renal disease in humans. Affected individuals present in early
adulthood with renal dysfunction and hypertension, which often
leads to renal failure during the sixth decade of life. The disease
is characterized by the formation of large fluid-filled cysts in all
segments of the nephron and pathological manifestations in other
organs [1, 2].
Recently a rat strain with autosomal dominant polycystic kidney
disease (P1(D) was described by Kaspareit-Rittingshausen et al
[3—7]. In their breeding colony the authors noted that rats from a
Sprague-Dawley strain suffered from PKD, and developed uremia
and hypertension. Azotemia was only observed in male rats. This
observation was subsequently confirmed by a number of other
groups [8—14]. Extrarenal organ manifestations of PKD, like cysts
in liver or pancreas, have been observed in humans, but not in
these rats.
In this paper we describe the occurrence of azotemia and the
development of hepatic and pancreatic cysts in old female PKD
rats. In addition, the liver cysts were further characterized as
originating from bile duct epithelia and exhibiting similar extra-
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cellular matrix alterations as noted from renal cysts. Therefore,
our findings provide additional evidence that this animal model
resembles the human disease.
Methods
In this investigation heterozygous affected and homozygous
unaffected female rats originating from the Han:SPRD [13, 14]
strain originally obtained from Dr. Deerberg (Central Institute for
Laboratory Animal Breeding, Hannover, Germany) were studied.
All rats had free access to tap water and standard rat chow (1324
Altromin, Lage, Germany) containing 19% protein. The light
cycle was 12 hours, humidity 55%, and room temperature 20°C.
One group of animals was studied at the age of two months (N =
137) and the other at the age of 21.3 2.6 months (N = 67).
Fourteen of the 67 rats died naturally and were necropsied,
while 53 were sacrificed for the study under ketamine/xylazine
anesthesia. Blood samples were taken from the aorta. Serum urea,
serum creatinine, cholesterol and triglycerides were determined
using a Hitachi automatic analyzer (Boehringer Mannheim).
Body weight, wet weight of the kidneys and the heart was
recorded. The carrier status of the affected animals was ascer-
tained by the presence of renal cysts.
Kidneys, pancreas, spleen, lungs, heart and samples of the three
largest lobes of the liver were fixed in 3% buffered formalin and
embedded in paraffin. For light microscopy paraffin sections were
stained with eosin-hematoxylin. In animals exhibiting liver cysts,
small portions of cystic areas were prepared for transmission
electron microscopy and frozen sections were used for immuno-
histochemical detection of extracellular matrix proteins and cyto-
keratin 19. Sections were preincubated with 5% goat serum or 2%
bovine serum albumin to block nonspecific binding. After exten-
sive washing with phosphate buffer sections were incubated with
the primary antibody for 16 hours, extensively washed and then
incubated again for 60 minutes with the FITC-conjugated second-
ary antibody.
For immunohistochemistry the following antibodies were used:
mouse monoclonal IgG2 anti-cytokeratin 19 (Amersham, Braun-
schweig, Germany), polyclonal rabbit anti-rat collagen I (Biode-
sign, distributed by Dunn, Asbach, Germany), polyclonal rabbit
anti-rat fibronectin (Gibco, Eggenstein, Germany), 1M403 (a
monoclonal mouse anti-heparan sulfate proteoglycan directed
against GAG [15]) and B-31, polyclonal goat anti-heparan sulfate
proteoglycan core protein [16] (provided by Dr. Berden, Nijme-
gen, The Netherlands, and Prof. van der Woude, Mannheim,
Germany), polyclonal rabbit anti-rat laminin (Biomol, Hamburg,
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Fig. 1. (top panel) Renal histology in a female
Han:SPRD (cy/+) rat aged 25 months (HE-stain,
magnification x100).
Fig. 2. (bottom panels) Liver and pancreas
histology in female Han:SPRD (cy/+) rats aged
25 months. A. Hepatic cysts (HE-stain,
magnification x 100). B. Pancreatic cysts (HE-
stain, magnification x 100).
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Table 1. Characterization of affected and unaffected female rats of the
PKD strain
Affected Unaffected P
Young age group
(2 months)
Body weight g 211 15 209 17 0.2216
Kidney weight g 2.28 0.40 1.45 0.26 0.0001
kw/bwgl]OOg 1.10 0.15 0.67 0.06 0.0001
Heart weight g 0.86 0.17 0.83 0.12 0.1931
hwlbw g/JOO g 0.41 0.08 0.40 0.06 0.4052
Sra mg/dl 38 5 37 4 0.1704
Sr mg/dl 0.29 0.04 0.29 0.03 0.35 15
Triglycerides mgldl 150 46 135 45 0.0432
Cholesterol mg/dl 76 9 76 9 0.983 1
Older age group
Age months 21.5 2.7 21.1 2.6 0.5772
Body weight g 357 63 344 51 0.4118
Kidney weight g 4.29 2.05 2,12 0.41 0.0001
kwlbw g/100 g 1.26 0.76 0.63 0.15 0.0003
Heart weight g 1.67 0.29 1.45 0.18 0.0016
hwlbw g/100g 0.49 0.14 0.43 0.07 0.0603
Sura mg/dl 95.3 124 43 7.7 0.0416
Sr mg/dl 0.82 1.1 0.45 0.07 0.0962
Triglycerides mg/dl 231 139 166 84 0.0454
Cholesterol mg/dl 149 63 123±31 0.0645
Abbreviations are: kw/bw, kidney weight of both kidneys corrected for
body weight; hw/bw, heart weight corrected for body weight; Surc, serum
urea concentration; S, serum creatinine concentration.
Germany), as secondary antibodies FITC-conjugated goat anti-
rabbit IgG (Sigma, Munich, Germany), FITC-conjugated goat
F(ab)2 fragment anti-mouse IgG (Cappel, distributed by Or-
ganon, Eppelheim, Germany), FITC-conjugated rabbit anti-goat
IgG (Dako, Hamburg, Germany) and FITC-conjugated rabbit
anti-mouse (Dako).
Data were analyzed using the SAS computer software package;
the following procedures were applied: PROC iTEST and PROC
UNIVARIATE [17, 18]. Data are given as mean SD.
Results
In the younger animals (2 months) no difference was noted
(Table 1) between the affected (N = 74) and unaffected (N = 63)
female rats with respect to body wt, heart weight, serum urea,
serum creatinine and cholesterol concentration. Triglycerides
were only marginally raised, while kidney weight was considerably
higher in affected rats. No liver cysts were noted in this age group.
In the older age group the mean age of the heterozygous
affected females was 21.5 2.7 months (minimum 17.7 months,
maximum 27.9 months) and did not differ significantly from the
age of homozygous unaffected controls (mean 21.1 2.6 months;
minimum 17.1 month; maximum 28.1 month).
In the 53 older rats that were sacrificed for this study, blood
samples could be obtained for biochemical analysis (Table 1).
Significantly higher values for kidney weight, serum urea and
triglycerides were noted in the affected in comparison to the
unaffected rats. Serum creatinine and cholesterol levels revealed
differences of only marginal significance. Analyzing the data of the
affected rats according to the occurrence of liver cysts showed no
significant differences (Table 2), although there seemed to be a
trend towards a more pronounced azotemia in animals exhibiting
liver cysts.
Renal histology of these old heterozygous females revealed
Table 2. Characterization of affected female rats of the older age
group according to the occurrence of liver cysts
Liver cysts
(N=13)
No liver cysts
(N=13) P
Age months 22.2 3.1 20.8 2.0 0.2025
Body weight g 341 72 374 51 0.1923
Kidney weight g 4.02 1.01 4.55 2.8 0.5248
kwlbwgllOOg 1.21 0.34 1.31 1.04 0.7497
Heart weight g 1.69 0.34 1.65 0.25 0.6958
hwlbw gIlOO g 0.52 0.17 0.45 0.09 0.2038
Sra mg/dl 118 164 72 63 0.3589
Scr mg/dl 0.96 1.45 0.69 0.60 0.5361
Triglycerides mg/dl 227 153 235 130 0.8826
Cholesterol mg/dI 142 46 157 77 0.5637
Abbreviations are: kw/bw, kidney weight of both kidneys corrected for
body weight; hwlbw, heart weight corrected for body weight; Sure, serum
urea concentration; Se,, serum creatinine concentration.
similar changes as in the previously described affected male
animals (Fig. 1). The renal tissue was composed of irregular cysts
of varying size, often filled with cosinophilic casts. Severe fibrosis
and marked inflammatory infiltration could also be seen. No such
changes were noted in control animals, in which occasionally
slight interstitial mononuclear infiltrates and moderate glomeru-
lar changes were found.
Liver cysts were noted in 16 out of 38 heterozygous female PKD
rats (42%), but only in one animal (3%) of the 29 homozygous
unaffected rats of the same age range (Fisher's exact test, P
0.0002). The liver cysts were localized predominantly under the
serosa, varied in size from 1 to 7 mm and contained a clear watery
fluid. In most of the cases multiple cysts built a network-like
structure.
The cysts were lined by a monolayer of flattened or cuboidal
epithelial cells (Fig. 2A). Small trabeculae composed of thin layers
of connective tissue ran between the cysts. Adjacent liver tissue
sometimes showed signs of vacuolating degenerative or fatty
changes, especially when nests of hepatocytes were encircled and
compressed by cysts. Localized cellular inflammatory infiltrations
(lymphocytes and macrophages) were noted in the trabeculae.
Yellow-brown intra- or extracellular pigments were often seen in
the connective tissue. In the periphery of the cysts, connections to
the cannalicular system were found that corresponded morpho-
logically to bile ducts. The remaining liver tissue in all animals of
the older age group exhibited moderate periportal fibrosis,
marked bile duct proliferation and moderate inflammatory infil-
trations, mainly in the connective tissue of the portal areas.
Eosinophilic and basophilic foci were occasionally seen. Lesions
like microhamartomas [19] were not noted in affected nor in
unaffected rats.
No cysts could be detected in the spleen or the lungs of the
animals, whereas the pancreas of 26 affected (69%) and of 4
unaffected animals (15%) showed microcystic changes, degener-
ative acini and in some cases larger cysts lined by a flattened
epithelium (Fisher's exact test, P < 0.0001; Fig. 2B). These
pancreatic cysts were more distinct and larger in the affected
animals with liver cysts (10 of 12) than in affected animals without
liver cysts (5 of 14; Fisher's exact test, P = 0.0187).
Transmission electron microscopy (Fig. 3) of the liver cysts
revealed flattened cyst-lining epithelium, resting on a basal lamina
supported by collagenous connective tissue. The cells showed
C'
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Fig. 3. Electron microscopy of a liver cyst
(magnification X3400; inset X15000).
numerous apical microvilli with some folds and interdigitations on
the lateral surfaces. They contained only sporadic organdies and
were joined to one another by tight junctions, characteristic of bile
duct epithelium.
As shown by immunohistochemistry, hepatic cyst epithelia
stained strongly positive for cytokeratin 19, suggesting that the
epithelium was derived from biliary epithelial cells (Fig. 4).
Furthermore, cysts stained strongly positive for heparan sulfate
proteoglycan, as observed with the antibody directed against the
GAG chains as well as the one directed against the core protein.
Heparan sulfate proteoglycan in normal liver was only expressed
by biliary epithelium and in vessels. Laminin and fibronectin could
also be detected in the cyst lining epithelia, while cysts stained
negative for collagen I. In normal liver fibronectin was present in
the Disse's space, while laminin could be noted in the basement
membranes of bile ductules and large vessels.
The extracellular matrix composition of the liver cysts were in
line with the one found in renal cysts of the same animals (Fig. 5):
in kidney sections, two different antibodies against heparan sulfate
proteoglycan (one directed against the core protein, the other one
against heparan sulfate) stained the cyst lining epithelia, the
glomerular and tubular basement membranes and vessels (Fig.
5A). Laminin was noted in the epithelial lining of cysts, the
glomerular and tubular basement membrane as well as in the
intima of arterial vessels (Fig. 5B). Fibronectin could be localized
in renal cyst lining epithelia, mesangium and in the interstitium.
Interstitial fibronectin staining appeared to be even stronger in
direct neighborhood of cysts (Fig. 5C). Collagen I was present in
the interstitium and appeared enhanced in the cyst lining epithelia
of only a few cysts or in close neighborhood to the cysts (Fig. SD).
Discussion
Our data clearly reveal that azotemia occurs in female Han:
SPRD (cyl+) rats, if the animals are allowed to age. In this rat
strain suffering from PKD no extrarenal manifestations of PKD
had been noted so far. We describe and characterize hepatic and
pancreatic cysts as extrarenal organ manifestation in these ani-
mals.
In previous descriptions of the course of PKD in the Han:SPRD
(cy/+) rat, female animals were observed up to an age of 14
months [101. During this observation period no signs of renal
functional impairment occurred. In our colony, however, we
noted increased serum urea and serum creatinine values in
affected female rats aged 17 months or older. Furthermore, an
increased death rate became evident. Testing systematically for
serum urea and creatinine revealed azotemia in this age group.
Compatible with these functional findings are the changes in renal
histology (Fig. 1), where numerous small, medium and large cysts,
marked fibrosis and inflammatory infiltration were found. Thus
from our data it becomes obvious that both affected male and
female PKD rats develop azotemia due to cystic disease with
females developing azotemia at a much older age than males.
Mean observation period in this study was 22.3 2.6 months
(N = 67), which is significantly longer than the median survival of
affected male rats (median 17.0 months) [13]. Thus, as also noted
in humans [20, 21], a significant gender difference seems to exist
with respect to the occurrence of renal death. A similar difference
was observed in another rat model of renal disease, the fawn
hooded rat [22—24]. From our data survival time cannot be
calculated in the female group, as only a cross-sectional study was
performed. This notion is calling for a formal study to establish
survival rates/survival curves in female Han:SPRD (cy/+) rats as
has already been done in their male counterparts [13].
Extrarenal manifestations of human PKD include cardiac val-
vular abnormalities, colonic diverticuli, cerebrovascular aneu-
rysms and the occurrence of cysts in various organs [1, 2, 25].
About 70% of all patients develop liver cysts by the age of 60 years
while cysts in other organs (pancreas, ovary, testis, spleen and
meninges) are very rare [1]. Massive hepatic cystic disease mainly
occurs in women and is influenced by the number of pregnancies
and the use of oral contraceptives. In old female PKD rats (> 17
months) we noted the occurrence of liver cysts in 42% of all cases.
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Fig. 4. Liver cyst epithelium (left) and portal
tract (right) in heterozygous affected female PKD
rats aged 25 months showed strong
immunoreactivity for (A) cytokeratin 19 (FJTC-
immunostaining, magnification X100), (B)
heparan salfate proteoglycan (FITC-
immunostaining, X100, (C) laminin (FITC-
immunostaining, X100), (D) fibronectin (FITC-
immunostaining, >< 100), (E) bat not for collagen
I (FITC-immanostaining, X100).
Kränzlin et at: Azotemia and extrarenal manifestations in PKD rats 1165
Fig. 4. Continued.
No correlation between the number of pregnancies and the
development of liver cysts could be detected (data not shown). In
younger female heterozygous rats up to the age of one year, no
renal functional impairment and also no extrarenal manifesta-
tions, like liver cysts, were noted (data not shown). Admittedly,
however, no large scale study was performed by us and others. In
addition, it is of note that in male heterozygous rats dying of
uremia [13] no liver cysts were observed. Thus, the extent of renal
functional impairment and extrarenal manifestations seems to be
a function of age in this rat model. Interestingly, the female rats
exhibiting liver cysts seemed to exhibit a higher degree of
azotemia, though this was statistically not significant. This trend,
however, seems to be associated with a slightly older age in this
group of rats.
In rats hepatic cysts and proliferative lesions of the biliary
epithelium are often described following liver injury or treatment
with carcinogens [26—281. Single or multiple cysts, however, may
also occur in untreated rats [29, 301. The incidence of spontaneous
liver cysts in rats differs with respect to the strain and normally
increases with age. In two different strains (WAG/Rij (Wistar)
and BN/Bj) liver cysts developed in not more than 10% of all
animals up to an age of 30 months. Older female rats (WAG!
Rij > 36 months; BN/Bj 30 to 54 months) exhibited liver cysts in
30% or 55% of all cases [31]. In Sprague-Dawley (SD) rats a low
incidence of 2.3% in male and 1% in female rats older than 18
months was described [32]. As our PKD strain originates from SD
rats, one would expect a low incidence of liver cysts. As we
observed cysts only once in an unaffected rat (3%) of the same
age, the high incidence (42%) seems to be a specific feature of
affected old female PKD rats.
The hepatic cysts seen in PKD rats resembled the cysts in
humans in two ways (Figs. 2A and 3): they could only be seen at
an older age (> 17 months) and the cyst epithelium appeared to
be similar to biliary duct epithelium (light and transmission
electron microscopy). Histomorphometric and microdissection
studies of liver cysts of patients with autosomal dominant PKD
indicated that cysts begin as focal dilations of the intrahepatic bile
ducts [33]. Furthermore, hepatic cyst epithelium has functional
characteristics of biliary epithelium [34, 351. In addition liver
cyst-derived epithelial cells in culture from female patients with
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Fig. 5. Extracellular matrix protein expression in
PKD rat kidneys. A. Heparan sulfate
proteoglycan in the glomerular basement
membrane, the mesangium and in larger vessels
as well as in cyst-lining epithelia (FITC-
immunostaining, magnification >( 100). B. Anti-
laminin reactivity in glomerular and tubular
basement membrane, larger vessels as well as
cyst-lining epithelia (FITC-immunostaining,
Xl 00). C. Positive fibronectin staining in the
cyst-lining epithelia, the mesangium, large
vessels as well as in the interstitium (FITC-
immunostaining, X100). D. Collagen I in the
interstitium and in cyst-lining epithelia of few
cysts (FITC-immunostaining, magnification
X100).
PKD exhibit characteristics of intrahepatic biliary epithelium [36].
Similarly, rat liver cyst epithelium showed strong immunoreactiv-
ity for cytokeratin 19, a specific marker for biliary epithelium (Fig.
4A) [37], and for heparan sulfate proteoglycan, the latter normally
only found with biliary epithelium and vessels [38], Therefore, the
epithelial lining could be classified as a proliferative cystic lesion
of biliary epithelium.
Pancreatic cysts were found in human PKD in 9% [1]. In the
pancreas of all our old female rats (> 17 months), either affected
and unaffected animals, we noted the occurrence of microcystic
changes (Fig. 2B) in 42%. Since these changes are also a
phenomenon related to age [30] care has to be taken when
interpreting the results. We found a relationship between the
frequency of pancreatic cysts and PKD: 69% of the affected, but
only 15% of the unaffected animals showed cystic changes.
Furthermore, the cystic changes in the pancreas of affected
animals with liver cysts were more marked and the rats exhibited
larger cysts (10 of 12 animals) than affected animals without liver
cysts (5 of 14 animals).
In the liver several extracellular matrix proteins have been
described and localized [38]. In normal histological staining, a
basement membrane cannot be detected except around the biliary
ductules and major vessels [39]. Collagen IV, laminin and heparan
sulfate proteoglycans have been shown to be its major constitu-
ents, while fibronectin is mostly localized in the space of Disse.
Collagen I is sparsely distributed in bundles across the lobule [38].
Similarly in the kidney, collagen I and fibronectin are mostly
found in the interstitium, the latter also representing the main
extracellular matrix component of the mesangium. Laminin and
collagen IV are the main constituents of basement membranes,
In different models of PKD an early change in renal extracel-
lular matrix composition has been described [40—43] with dra-
matic changes in the expression of fibronectin and collagen I. An
early increase in mRNA levels of fibronectin, collagen I, collagen
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Fig. 5. Continued.
IV and laminin in the pcy mouse model was noted [40]. In DPT
induced PKD in the rat, Carone et a! [41] detected intense
staining for fibronectin in the basement membrane of cystic
tubular epithelia and a decrease in anti-heparan sulfate proteo-
glycan core protein reactivity. These findings were in line with
data observed in human PKD [42], where an increase in fibronec-
tin staining and a loss of anti-heparan sulfate proteoglycan core
protein staining was described. In a corticoid induced model of
cystic disease in rabbits, Ojeda et a! [43] reported an increase in
fibronectin staining of cystic tubuli and an unchanged or slightly
decreased reactivity of cystic basement membrane with anti-
laminin and anti-collagen IV. In our study extracellular matrix
composition of renal cysts in the older female PKD rats resembled
published data, except for an increase in heparan sulfate proteo-
glycan staining of the cyst lining epithelia.
An overall increase in the concentration of low molecular
weight glycoproteins has been shown by biochemical analysis [44].
The difference in heparan sulfate proteoglycan protein expres-
sion, as found by immunohistochemistry, might be due either to a
different recognition site of the antibody or to the fact that a
different, inherited model of PKD was studied. It might also be
explained by the different stages of the disease, which were
studied. While Carone et a! [41] examined early changes in the
DPT rat model, two-year-old female rats were studied in the
present study. Our findings are corroborated by the fact that two
different antibodies against heparan sulfate proteoglycan were
used exhibiting similar results. Furthermore, the general tissue
distribution found in liver and kidney is in line with the localiza-
tion described by others [15, 16].
Similarly to the extracellular matrix composition found in renal
cysts (Fig. 5), the cyst-lining epithelia in PKD rat liver stained
strongly positive for fibronectin, heparan sulfate proteoglycan and
laminin, while no increase in anti-collagen I reactivity was observed
(Fig. 4). As the cystic epithelia stained positive for cytokeratin 19
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and heparan sulfate proteoglycan, it seems to be derived from
biliary duct epithelium. The resemblance of extracellular matrix
changes between renal and liver cysts suggests a similar process of
cystogenesis to take place in liver and kidney, adding to the notion
that the Han:SPRD (cy/+) rat model represents a multi-organ
disease.
In summary, we could demonstrate that older affected female
PKD rats are suffering from azotemia and that these rats develop
hepatic and pancreatic cysts as signs of an extrarenal organ
manifestation. These features add to the resemblance of the
human disease. Furthermore, liver cysts were not only derived
from biliary duct epithelia like in human PKD, but also exhibited
similar changes in extracellular matrix composition as described
for renal cysts, indicating a similar process of cystogenesis taking
place in the liver of old female rats as observed in the kidney.
Thus, our findings underline that the Han:SPRD (cyl+)ratmodel
could be a useful tool to study the pathogenesis of human PKDas
a multiorgan disease.
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